Entesar F. Amin

730 total citations
15 papers, 583 citations indexed

About

Entesar F. Amin is a scholar working on Pathology and Forensic Medicine, Surgery and Hepatology. According to data from OpenAlex, Entesar F. Amin has authored 15 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Surgery and 4 papers in Hepatology. Recurrent topics in Entesar F. Amin's work include Liver Disease and Transplantation (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Entesar F. Amin is often cited by papers focused on Liver Disease and Transplantation (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Entesar F. Amin collaborates with scholars based in Egypt and Saudi Arabia. Entesar F. Amin's co-authors include Rehab Ahmed Rifaai, Aly M. Abdelrahman, Rania Abdellatif, Salwa A. Ibrahim, Mohamed Ibrahim, Mohamed A. Morsy, Mina Kelleni, Maha Yehia Kamel, Nashwa Fathy Gamal El‐Tahawy and Marwa M. M. Refaie and has published in prestigious journals such as Life Sciences, European Journal of Pharmacology and BioMed Research International.

In The Last Decade

Entesar F. Amin

15 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Entesar F. Amin Egypt 13 155 120 111 94 73 15 583
Davoud Sanajou Iran 16 242 1.6× 167 1.4× 87 0.8× 92 1.0× 87 1.2× 26 740
Yousuf Al Suleimani Oman 14 137 0.9× 101 0.8× 106 1.0× 38 0.4× 68 0.9× 24 525
Ivan Rubio‐Gayosso Mexico 15 174 1.1× 173 1.4× 76 0.7× 80 0.9× 79 1.1× 36 783
Nashwa Fathy Gamal El‐Tahawy Egypt 14 136 0.9× 76 0.6× 70 0.6× 37 0.4× 53 0.7× 52 571
Xiangdong Yang China 18 297 1.9× 61 0.5× 122 1.1× 76 0.8× 90 1.2× 57 975
Predrag Vlahović Serbia 19 172 1.1× 162 1.4× 52 0.5× 76 0.8× 107 1.5× 65 781
Rania Abdellatif Egypt 13 135 0.9× 128 1.1× 58 0.5× 24 0.3× 72 1.0× 26 526
Sohachi Fujimoto Japan 13 181 1.2× 100 0.8× 123 1.1× 163 1.7× 96 1.3× 18 747
Yuka Kohda Japan 14 150 1.0× 53 0.4× 175 1.6× 77 0.8× 42 0.6× 35 586
Nagla A. El-Sherbeeny Egypt 14 151 1.0× 40 0.3× 60 0.5× 101 1.1× 61 0.8× 26 536

Countries citing papers authored by Entesar F. Amin

Since Specialization
Citations

This map shows the geographic impact of Entesar F. Amin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Entesar F. Amin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Entesar F. Amin more than expected).

Fields of papers citing papers by Entesar F. Amin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Entesar F. Amin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Entesar F. Amin. The network helps show where Entesar F. Amin may publish in the future.

Co-authorship network of co-authors of Entesar F. Amin

This figure shows the co-authorship network connecting the top 25 collaborators of Entesar F. Amin. A scholar is included among the top collaborators of Entesar F. Amin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Entesar F. Amin. Entesar F. Amin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ibrahim, Salwa A., et al.. (2021). Nitric Oxide Modulation as a Potential Molecular Mechanism Underlyingthe Protective Role of NaHS in Liver Ischemia Reperfusion Injury. Current Molecular Pharmacology. 15(4). 676–682. 6 indexed citations
2.
Fouad, Amr A., et al.. (2020). Naringenin and Vanillin Mitigate Cadmium-Induced Pancreatic Injury in Rats via Inhibition of JNK and p38 MAPK Pathways. Pharmacognosy Journal. 12(4). 742–748. 7 indexed citations
3.
Abdellatif, Rania, Rehab Ahmed Rifaai, & Entesar F. Amin. (2020). Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathway. Archives of Pharmacal Research. 43(5). 514–525. 71 indexed citations
4.
Amin, Entesar F., Rehab Ahmed Rifaai, & Rania Abdellatif. (2020). Empagliflozin attenuates transient cerebral ischemia/reperfusion injury in hyperglycemic rats via repressing oxidative–inflammatory–apoptotic pathway. Fundamental and Clinical Pharmacology. 34(5). 548–558. 80 indexed citations
5.
Ibrahim, Mohamed, et al.. (2019). Allopurinol potentiates the hepatoprotective effect of metformin and vitamin E in fructose-induced fatty liver in rats. Clinical and Experimental Hepatology. 5(1). 65–74. 12 indexed citations
6.
Refaie, Marwa M. M., Entesar F. Amin, Nashwa Fathy Gamal El‐Tahawy, & Aly M. Abdelrahman. (2016). Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats. Journal of Toxicology. 2016. 1–9. 62 indexed citations
7.
Abdel-Gaber, Seham A., et al.. (2015). Effect of selective versus non-selective cyclooxygenase inhibitors on ischemia–reperfusion-induced hepatic injury in rats. Life Sciences. 134. 42–48. 27 indexed citations
8.
Kelleni, Mina, Entesar F. Amin, & Aly M. Abdelrahman. (2015). Effect of Metformin and Sitagliptin on Doxorubicin-Induced Cardiotoxicity in Rats: Impact of Oxidative Stress, Inflammation, and Apoptosis. Journal of Toxicology. 2015. 1–8. 64 indexed citations
9.
Hafez, H. M., et al.. (2015). Potential protective effect of etanercept and aminoguanidine in methotrexate-induced hepatotoxicity and nephrotoxicity in rats. European Journal of Pharmacology. 768. 1–12. 65 indexed citations
10.
Ibrahim, Mohamed, et al.. (2014). Molecular mechanisms contributing to the protective effect of levosimendan in liver ischemia-reperfusion injury. European Journal of Pharmacology. 741. 64–73. 22 indexed citations
11.
Morsy, Mohamed A., et al.. (2014). Sildenafil Ameliorates Gentamicin-Induced Nephrotoxicity in Rats: Role of iNOS and eNOS. Journal of Toxicology. 2014. 1–7. 37 indexed citations
12.
Morsy, Mohamed A., et al.. (2014). Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats. BioMed Research International. 2014. 1–8. 16 indexed citations
13.
Ibrahim, Mohamed, Entesar F. Amin, Salwa A. Ibrahim, Walaa Yehia Abdelzaher, & Aly M. Abdelrahman. (2013). Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats. European Journal of Pharmacology. 724. 204–210. 29 indexed citations
14.
Morsy, Mohamed A., et al.. (2013). Curcumin Ameliorates Methotrexate-Induced Nephrotoxicity in Rats. Advances in Pharmacological Sciences. 2013. 1–7. 66 indexed citations
15.
Morsy, Mohamed A., et al.. (2009). Gastroprotective effects of telmisartan on experimentally-induced gastric ulcers in rats.. PubMed. 64(9). 590–4. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026